Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Epilepsy × Neuropsychological Tests × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Brain Neoplasms 12 Cognitive Dysfunction 4 Radiation Injuries 3 Neoplasms 3 Glioma 3 Breast Neoplasms 3 Multiple Myeloma 2 Glioblastoma 2 Fatigue 2 Colorectal Neoplasms 2 Astrocytoma 2 Triple Negative Breast Neoplasms 1 Stroke 1 Sarcoma 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Parkinson Disease 1 Osteosarcoma 1 Oligodendroglioma 1 Neurofibromatosis 1 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Localized, Operable Non-small Cell Lung Cancer 1

Interventions

Sirolimus 4 LY3295668 erbumine 3 Everolimus 3 Medical Marijuana 2 Anticonvulsants 2 ziprasidone 1 perampanel 1 enzalutamide 1 clevidipine 1 brivaracetam 1 Zolpidem 1 Warfarin 1 Vigabatrin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Topotecan 1 Tobramycin 1 Therapeutic Touch 1 Temozolomide 1 TAS-119 1 Surgical Procedures, Operative 1 Sulfasalazine 1 Spironolactone 1 Sevoflurane 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Registries 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02320136 2023-12-01

HFO

University of Zurich

Epilepsy, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡